Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Melanoma-related topics and the MedlinePlus Genetics related links were removed from the page's related topics section.
    Difference
    0.2%
    Check dated 2026-03-26T11:19:11.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Melanoma and related topics, including MedlinePlus Genetics, and updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T21:19:52.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    - Revision metadata updated: added Revision: v3.4.3. The Melanoma label and the MedlinePlus Genetics topic were removed, and Revision: v3.4.2 was deleted.
    Difference
    0.2%
    Check dated 2026-03-11T18:12:33.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as a related topic on the page.
    Difference
    0.2%
    Check dated 2026-03-04T14:20:51.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Added related topics Melanoma and MedlinePlus Genetics to the study page.
    Difference
    0.2%
    Check dated 2026-02-25T10:42:41.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics were removed from the related topics section on the page.
    Difference
    0.2%
    Check dated 2026-02-18T06:53:21.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.